HIF1A and experimental autoimmune encephalomyelitis: Based on this, they developed a synthetic lactate-producing probiotic, which successfully suppressed T cell-driven central nervous system autoimmunity in experimental autoimmune encephalomyelitis (EAE) models through the activation of HIF-1α–NDUFA4L2 signaling in DCs (63).